NCT00302133View on ClinicalTrials.gov

Optimizing Pharmacotherapy for Bipolar Alcoholics

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

88

Participants

Timeline

Start Date

May 31, 2006

Primary Completion Date

April 30, 2013

Study Completion Date

July 31, 2013

Conditions
Bipolar DisorderAlcohol Dependence
Interventions
DRUG

Naltrexone hydrochloride

Naltrexone hydrochloride 50 mg capsule daily for 12 weeks

OTHER

Placebo

Placebo arm

Trial Locations (1)

33136

University of Miami Miller School of Medicine, Miami

All Listed Sponsors
lead

University of Miami

OTHER

NCT00302133 - Optimizing Pharmacotherapy for Bipolar Alcoholics | Biotech Hunter | Biotech Hunter